Saintigny et al., for example, showed that EPO/EPOR co-expression is associated with poor survival in stage I NSCLC and suggested a potential role of endogenous EPO in the progression of these tumors [11]. The gene discussed is EPOR; the disease is non-small cell lung carcinoma.